Amfepentorex

Amfepentorex
INN: Amfepentorex
Clinical data
ATC code
  • none
Identifiers
  • (±)-N-methyl-1-(4-pentylphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H25N
Molar mass219.372 g·mol−1
3D model (JSmol)
  • N(C(Cc1ccc(cc1)CCCCC)C)C
  • InChI=1S/C15H25N/c1-4-5-6-7-14-8-10-15(11-9-14)12-13(2)16-3/h8-11,13,16H,4-7,12H2,1-3H3 checkY
  • Key:XWNBHORZFYYYIJ-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

Amfepentorex (INNTooltip International Nonproprietary Name) also known as CB-2201 is a stimulant drug derived from methamphetamine which was used as an appetite suppressant for the treatment of obesity, mainly in France in the 1970s.[1][2] Dosage is 50–100 mg per day. Side effects include insomnia, hypertension and acute glaucoma.

References

  1. ↑ Ganellin CR, Triggle DJ (1997). "A00258: Amfepentorex". Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
  2. ↑ "Amfepentorex". NCATS Inxight Drugs. Archived from the original on 2025-04-20.


This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.